For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Immunovant Inc (NASDAQ: IMVT) was $17.7 for the day, down -1.17% from the previous closing price of $17.91. In other words, the price has decreased by -$1.17 from its previous closing price. On the day, 0.7 million shares were traded. IMVT stock price reached its highest trading level at $18.32 during the session, while it also had its lowest trading level at $17.48.
Ratios:
Our analysis of IMVT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.16 and its Current Ratio is at 11.16. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 03, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 09 ’25 when Geffner Michael sold 1,160 shares for $17.24 per share. The transaction valued at 19,998 led to the insider holds 224,210 shares of the business.
Stout Jay S sold 1,519 shares of IMVT for $26,188 on Jul 09 ’25. The Chief Technology Officer now owns 207,724 shares after completing the transaction at $17.24 per share. On Jun 25 ’25, another insider, WILLIAM MACIAS, who serves as the Officer of the company, bought 30,000 shares for $15.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 3027921408 and an Enterprise Value of 2020898048.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.66, which has changed by -0.36035717 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 11.72%, while the 200-Day Moving Average is calculated to be -16.74%.
Shares Statistics:
IMVT traded an average of 1.28M shares per day over the past three months and 1210810 shares per day over the past ten days. A total of 170.11M shares are outstanding, with a floating share count of 68.63M. Insiders hold about 59.88% of the company’s shares, while institutions hold 55.49% stake in the company. Shares short for IMVT as of 1749772800 were 19918341 with a Short Ratio of 15.96, compared to 1747267200 on 21397625. Therefore, it implies a Short% of Shares Outstanding of 19918341 and a Short% of Float of 22.489999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of Immunovant Inc (IMVT) involves the perspectives of 8.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.63 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$2.51 and -$3.44 for the fiscal current year, implying an average EPS of -$2.86. EPS for the following year is -$2.82, with 8.0 analysts recommending between -$1.38 and -$3.98.
